Literature DB >> 12166072

[Current topics on urinary proteins: human albumin, protein 1, beta 2-microglobulin, and type IV collagen].

Yoshihisa Itoh1.   

Abstract

Current topics are presented on four urinary proteins under investigations with special emphasis on importance of preanalytical sampling and assay standardization. These comprise of albumin, protein 1 (P1), beta 2-microglobulin (beta 2-m), and Type IV collagen. Microalbuminuria is an essential marker for early diabetic nephropathy. The author is trying to reduce the discrepancy of urinary albumin value with value assignment from CRM470, BCR international reference material, to calibrator in each assay system. At the same time nonspecific binding of the protein on urine containers were found, which can cause the discrepancy. Furthermore structure of albumin both in calibrator and urine is important. Protein 1 is a low molecular weight nonglycoprotein of 14 kDa isolated from pathologic urine. Marked sex-related difference was noted in urine, being higher in male than female. This is due to the contamination from prostate. Its localization was finally demonstrated with immunohistochemical staining and a RT-PCR method. With the same methods the protein is demonstrated to be synthesized in female prostate. beta 2-m is easily degraded in acid urine. Employing various immunochemical methods and analyses of its amino acid sequences, we successfully identified cathepsin D as one of acid proteases responsible for the degradation. Urinary measurement of type IV collagen is now clinically under use for an independent marker for early diabetic nephropathy. Nonspecific elevation was observed in urine with UTI, in which mechanisms is should be clarified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12166072

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  1 in total

1.  Ultrasonography Combined with Blood Biochemistry on the Early Diagnosis of Diabetic Kidney Disease.

Authors:  Jing Lin; Guangde Liu; Yuxuan Lin; Chao Wei; Sujun Liu; Youhua Xu
Journal:  Dis Markers       Date:  2022-10-05       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.